FDA Scolds Supernus Pharmaceuticals Over Video Claims
A video from specialty drugmaker Supernus Pharmaceuticals Inc. wrongly implied that its anti-seizure medicine Oxtellar XR is approved for epilepsy and downplayed the risks of life-threatening side effects, according to a...To view the full article, register now.
Already a subscriber? Click here to view full article